Medicenna Therapeutics Corp.
Symbol:
TSX: MDNA
NQ: MDNA
Market Cap:
Private
Sector:
Healthcare
Summary:
Medicenna is a clinical stage immunotherapy company that uses directed evolution to generate engineered interleukins called Superkines that can modulate, fine-tune or amplify the immune system in order to combat the most challenging diseases and inspire hope in patients with unmet needs.